These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15352897)

  • 41. Review article: aminosalicylates for distal colitis.
    Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():41-4. PubMed ID: 16961744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease.
    Glas J; Török HP; Daczo J; Tonenchi L; Folwaczny M; Folwaczny C
    Eur J Med Res; 2005 Dec; 10(12):535-8. PubMed ID: 16356870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
    Gross V
    Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment strategies for inflammatory bowel disease].
    Lémann M; Allez M
    Rev Prat; 2005 May; 55(9):984-92. PubMed ID: 16052969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: the long-term management of ulcerative colitis.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():97-101. PubMed ID: 15352903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
    Van Assche G; Vermeire S; Rutgeerts P
    Curr Opin Gastroenterol; 2009 Jul; 25(4):323-8. PubMed ID: 19417645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
    Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pregnancy and labor in ulcerative colitis and Crohn disease].
    Moum B
    Tidsskr Nor Laegeforen; 2001 Jan; 121(3):322-5. PubMed ID: 11242875
    [TBL] [Abstract][Full Text] [Related]  

  • 51. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
    Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
    Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous cyclosporine for inflammatory bowel disease--safe and effective.
    Chermesh I; Tamir A; Lachter J; Eliakim R
    Hepatogastroenterology; 2007; 54(79):2003-6. PubMed ID: 18251148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
    Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
    Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
    Omer B; Krebs S; Omer H; Noor TO
    Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Advances in the topical steroid treatment of inflammatory bowel diseases].
    Díaz Blasco J; Robledo Andrés P
    Rev Esp Enferm Dig; 1995 Nov; 87(11):802-7. PubMed ID: 8534536
    [No Abstract]   [Full Text] [Related]  

  • 57. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M; Moum B
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral budesonide in the management of Crohn's disease.
    Hofer KN
    Ann Pharmacother; 2003 Oct; 37(10):1457-64. PubMed ID: 14519035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infliximab in the treatment of steroid-dependent ulcerative colitis.
    Armuzzi A; De Pascalis B; Lupascu A; Fedeli P; Leo D; Mentella MC; Vincenti F; Melina D; Gasbarrini G; Pola P; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2004; 8(5):231-3. PubMed ID: 15638236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
    Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
    Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.